β-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1238-1246

  Rickels, Michael R ^a   Mueller, Rebecca ^a   Teff, Karen L ^a   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; PROINSULIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 77749233948     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2289     Document Type: Article

References (40)

1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330
2. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL 2005 β-Cell function following human islet transplantation for type 1 diabetes. Diabetes 54:100-106
3. Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, In 't Veld P, Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D 2006 Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 103:17444-17449
4. Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM 2008 An examination of β-cell function measures and their potential use for estimating β-cell mass. Diabetes Obes Metab 10 (Suppl 4):63-76
5. Eriksson O, Eich T, Sundin A, Tibell A, Tufveson G, Andersson H, Felldin M, Foss A, Kyllönen L, Langstrom B, Nilsson B, Korsgren O, Lundgren T 2009 Positron emission tomography in clinical islet transplantation. Am J Transplant 9:2816-2824
6. Paty BW, Harmon JS, Marsh CL, Robertson RP 2002 Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73:353-357
7. Drachenberg CB, Klassen DK, Weir MR, Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S, Papadimitriou JC 1999 Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68:396-402
8. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC 2002 Posttransplantation diabetes. Diabetes Care 25:583-592
9. Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF 2007 Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357:2562-2575
10. Teuscher AU, Seaquist ER, Robertson RP 1994 Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 43:593-598
11. Christiansen E, Tibell A, Vølund A, Rasmussen K, Groth CG, Holst JJ, Pedersen O, Christensen NJ, Madsbad S 1996 Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab 81:3972-3979
12. Gillard P, Vandemeulebroucke E, Keymeulen B, Pirenne J, Maes B, De Pauw P, Vanrenterghem Y, Pipeleers D, Mathieu C 2009 Functional β-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation 87:402-407
13. Fernandez LA, Lehmann R, Luzi L, Battezzati A, Angelico MC, Ricordi C, Tzakis A, Alejandro R 1999 The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 68:1532-1541
14. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP 1990 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type 1 diabetic recipients. Diabetes 39:534-540
15. Rubenstein AH, Mako ME, Horwitz DL 1975 Insulin and kidney. Nephron 15:306-326
16. Meier JJ, Hong-McAtee I, Galasso R, Veldhuis JD, Moran A, Hering BJ, Butler PC 2006 Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 55:2324-2332
17. Ward WK, Halter JB, Beard JC, Porte Jr D 1984 Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 246:E405-E411
18. Seaquist ER, Robertson RP 1992 Effects of hemipancreatectomy on pancreatic α and β cell function in healthy human donors. J Clin Invest 89:1761-1766
19. Guldstrand M, Ahrén B, Adamson U 2003 Improved β-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557-E565
20. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH 1975 Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278-1283
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470
22. Desai NM, Goss JA, Deng S, Wolf BA, Markmann E, Palanjian M, Shock AP, Feliciano S, Brunicardi FC, Barker CF, Naji A, Markmann JF 2003 Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 76:1623-1625
23. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A 1994 Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 91:9253-9256
24. Robertson RP, Franklin G, Nelson L 1989 Intravenous glucose tolerance and pancreatic islet β-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporine. Diabetes 38:58-64
25. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS 1997 A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63:977-983
26. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B 2005 Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353:770-781
27. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T 2004 Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 15:3233-3239
28. Hui H, Khoury N, Zhao X, Balkir L, D'Amico E, Bullotta A, Nguyen ED, Gambotto A, Perfetti R 2005 Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 54:424-433
29. Marcelli-Tourvieille S, Hubert T, Moerman E, Gmyr V, Kerr-Conte J, Nunes B, Dherbomez M, Vandewalle B, Pattou F, Vantyghem MC 2007 In vivo and in vitro effect of sirolimus on insulin secretion. Transplantation 83:532-538
30. Lopez-Talavera JC, Garcia-Ocaña A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF 2004 Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 145:467-474
31. Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P, Roth E, Fürnsinn C, Promintzer M, Anderwald C, Bischof M, Roden M 2007 The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56:1600-1607
32. McAlister VC, Gao Z, Peltekian K, Domingues J, Mahalati K, MacDonald AS 2000 Sirolimus-tacrolimus combination immunosuppression. Lancet 355:376-377
33. Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DE, Gillingham KJ, Matas AJ 2005 A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients. An interim analysis. Am J Transplant 5:1529-1536
34. Bak MI, Grochowiecki T, Gałazka Z, Nazarewski S, Jakimowicz T, Pietrasik K, Wojtaszek M, Durlik M, Karnafel W, Szmidt J 2006 Proinsulinemia in simultaneous pancreas and kidney transplant recipients. Transplant Proc 38:280-281
35. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte Jr D, Robertson RP 1996 Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans. J Clin Invest 97:455-460
36. Hostens K, Ling Z, Van Schravendijk C, Pipeleers D 1999 Prolonged exposure of human β-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab 84:1386-1390
37. McDonald CG, Ryan EA, Paty BW, Senior PA, Marshall SM, Lakey JR, Shapiro AM 2004 Cross-sectional and prospective association between proinsulin secretion and graft function after clinical islet transplantation. Transplantation 78:934-937
38. Gruessner RW, Kandaswamy R, Humar A, Gruessner AC, Sutherland DE 2005 Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation 79:1184-1189
39. Barth RN, Janus CA, Lillesand CA, Radke NA, Pirsch JD, Becker BN, Fernandez LA, Chin L, Becker YT, Odorico JS, D'Alessandro AM, Sollinger HW, Knechtle SJ 2006 Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int 19:885-892
40. Gelens MA, Christiaans MH, van Heurn EL, van den Berg-Loonen EP, Peutz-Kootstra CJ, van Hooff JP 2006 High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation. Transplantation 82:1221-1223